Profhilo Demand Is Only Going Up. Here's How Smart Clinics Are Staying Stocked
Profhilo has earned its place as a fixture in most aesthetic clinic menus, and the trajectory isn't changing. Patient awareness of bioremodelling treatments has grown steadily, and practitioners who routinely offer Profhilo report high repeat rates - clients come back every six months, sometimes more frequently.
The challenge isn't persuading people it's worth doing. The challenge is keeping it in stock at a margin that makes clinical sense.
The demand shift over the past two years
It's worth understanding why Profhilo demand has held up so well even as some other aesthetic treatments have faced more price-sensitive patient behaviour. The treatment sits in an interesting position: it's minimally invasive, the results are natural-looking, and the two-session protocol fits well with how clinics prefer to structure follow-up appointments. Patients who've had it once tend to continue.
Clinics that weren't stocking Profhilo two years ago are often stocking it now, partly because the patient demand became impossible to refer out, and partly because the treatment protocols have become well-established and easier for trained practitioners to incorporate.
Where sourcing gets complicated
The growth in demand has also meant more suppliers entering the space. Some are authorised distributors with proper cold chain processes and transparent documentation. Others are operating in murkier territory, often competing on price alone.
For a product like Profhilo, where the treatment outcome depends heavily on the product arriving in the same condition it left the factory, who you buy from genuinely affects what you're injecting. This isn't a hypothetical risk - practitioners operating in B2B wholesale markets have seen cases of product that's been mishandled, stored improperly, or sourced through channels that can't be traced back to the original manufacturer.
The wholesale model that actually works for clinics
Clinics with a steady Profhilo demand are increasingly moving away from reactive, one-off purchasing and toward working with a small number of trusted wholesale suppliers with reliable stock and predictable delivery windows. This is particularly relevant for clinics that run Profhilo-specific treatment days or that include it as part of structured skin health programmes.
The practical question is which wholesale supplier to settle on. Bioresus's Profhilo range is one option practitioners are using for B2B purchasing in the European and UK markets - the platform is structured for clinical wholesale rather than one-off retail buying, which tends to mean cleaner pricing and more consistent availability.
Managing your Profhilo stock efficiently
Track how many treatments you're delivering per month and work backwards to your minimum stock requirement. Most practitioners doing regular Profhilo work need at least four to six ampoules on hand at any given time, depending on clinic size.
Order ahead of seasonal spikes. Early spring and September tend to see higher demand as patients come back after summer or want to look their best going into autumn. Suppliers can go out of stock during these periods, and last-minute sourcing often means paying a premium or compromising on your usual supplier.
Keep documentation for each batch you receive. Not only is this good clinical governance, but it's the foundation for responding to any patient query about product authenticity down the line.
The clinics that manage their Profhilo stock well are the ones treating it like the serious clinical product it is, not just another SKU. That starts with who you're buying from.
